Hepatitis B Virus Infection Clinical Trial
Official title:
The European HBV Registry: A Joint Initiative of TherVacB and DZIF
In order to tackle the unmet needs in chronic HBV infection, a consortium of clinical partners has gathered to establish a registry for patients with hepatitis B mono- and co-infections. The partners will build up a European-wide registry to be able to stratify patients for upcoming clinical trials. Extensive analyses of virus and host-specific parameters are to be carried out from these patients. The knowledge gained thereby should contribute to a better understanding of the HBV control and enable patient stratification with regard to immunomodulatory therapies. Furthermore, hepatitis B patients are to be identified who are willing to participate in future studies to investigate immunotherapies to cure HBV infections (e.g. therapeutic vaccines).
n/a
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT05392387 -
Treatment and Prognosis of Patients With Chronic HBV Infection
|
||
Recruiting |
NCT06023056 -
Hepatitis B Vaccination After Neonatal Surgery
|
||
Recruiting |
NCT03864263 -
Hepatitis B Virus Infection in Immunized Children With HBsAg-positive Parents
|
||
Completed |
NCT02798549 -
HBV Virions Bound Proteins
|
N/A | |
Recruiting |
NCT03695029 -
Maternal Screening and Antiviral Therapy in Pregnant Women to Reduce Mother-to-infant Transmission of Hepatitis B Virus
|
Phase 4 | |
Completed |
NCT00440297 -
Hepatitis B Vaccine Predialysis/Dialysis Study (V232-060)
|
Phase 3 | |
Terminated |
NCT03762681 -
A Study of RO7239958 to Evaluate Safety, Tolerability, Pharmacokinetics and Pharmacodynamics in Healthy Volunteers and Participants With Chronic Hepatitis B Virus Infection
|
Phase 1 |